New insights into childhood ependymomas.
Childhood ependymomas, which comprise approximately 10% to 15% of all brain tumors arising in patients less than 18 years of age, remain a highly problematic group of tumors to treat. Relapse-free survival rates vary significantly in contemporary series, and therapeutic approaches remain unsettled.
Packer
Roger J
RJ
Division of Neurology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA. rpacker@cnmc.org
D001932:Brain Neoplasms / Q000517:prevention & control / Q000532:radiotherapy*; D002648:Child; D004806:Ependymoma / Q000517:prevention & control / Q000532:radiotherapy*; D006801:Humans; D055502:Secondary Prevention
J Clin Oncol. 2001 Mar 1;19(5):1288-96
11230470
Pediatr Neurosurg. 1998 Apr;28(4):215-22
9732252
Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):52-7
12007941
Med Pediatr Oncol. 1998 Jun;30(6):319-29; discussion 329-31
9589080
Cancer. 2004 Mar 15;100(6):1230-7
15022291
J Clin Oncol. 2004 Aug 1;22(15):3156-62
15284268
J Pediatr Hematol Oncol. 1999 May-Jun;21(3):203-11
10363853
Cancer. 2003 Nov 15;98(10):2232-44
14601094
Neurosurgery. 1995 Oct;37(4):655-66; discussion 666-7
8559293